Related Experiment Video
Updated: Jul 12, 2026
05:57
The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Antihypertensive medications and anemia.
Domenic A Sica1, Rosemarie Mannino
1Division of Nephrology, Virginia Commonwealth University Health System, Richmond, VA 23298-0160, USA. dsica@mcuh-vcu.edu
Journal of Clinical Hypertension (Greenwich, Conn.)
|September 6, 2007
Summary
Antihypertensive medications can lower hemoglobin levels, potentially causing anemia. This effect, linked to hemodilution or reduced red blood cell production, warrants consideration in patients on these drugs.
Area of Science:
- Pharmacology
- Hematology
- Nephrology
Background:
- Antihypertensive medications are widely prescribed for managing high blood pressure.
- A known side effect of some antihypertensive drugs is a reduction in hemoglobin concentration.
- This reduction can range from minor to clinically significant anemia.
Purpose of the Study:
- To explore the association between antihypertensive medication use and changes in hemoglobin concentration.
- To elucidate the mechanisms behind medication-induced hemoglobin reduction.
- To highlight the importance of considering antihypertensive therapy in unexplained anemia.
Main Methods:
- Review of existing literature on antihypertensive drug effects on hematological parameters.
- Analysis of case studies reporting anemia in patients using antihypertensive medications.
- Discussion of proposed mechanisms including hemodilution, hemolysis, and erythropoiesis suppression.
Main Results:
- Antihypertensive medication use is associated with decreased hemoglobin levels.
- Mechanisms include hemodilution, hemolytic anemia, and suppressed red blood cell production.
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are commonly implicated.
Conclusions:
- Clinicians should consider antihypertensive therapy as a potential cause of anemia.
- Unexplained anemia in hypertensive patients warrants evaluation for medication side effects.
- Monitoring hemoglobin levels may be necessary for patients on certain antihypertensive agents.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:16Antihypertensive Drugs: Action of Diuretics
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...